Lymphoplasmacytic Lymphoma (LGL)/Waldenstrom Macroglobulinemia (WM) is a type of non-Hodgkin lymphoma (NHL). The cancer cells make large amounts of an abnormal protein (called a macroglobulin). To learn more about the disease watch video featuring Dr. Jeffrey Matous and Megan Andersen, APP

Imbruvica has been approved by the FDA for treatment of adults with WM in combination use with Rituximab. NEJM

Learn more about the signs and symptoms

View article on Medscape